Catalyst Wire Dossier Catalyst Wire Dossier

Allogeneic human mesenchymal stem cell infusion

mesenchymal stem cells (allogeneic) · Daewoong Group Indonesia
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Allogeneic human mesenchymal stem cell infusion, covering 2026-01-09 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic Human Mesenchymal Stem Cell Infusion for Frailty Patient [NA]

See pricing